Biotechnology Value Trading Fund OS LP, 10% Owner at FIVE PRIME THERAPEUTICS, INC. (FPRX), bought 55,723 shares at $3.68 ($205K) on 2019-10-08, disclosed to the SEC on 2019-10-08.
Open-market purchase of $205k FPRX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.68 | 24,716 | $91K | 44.4% |
| 2 | $3.68 | 31,007 | $114K | 55.6% |
| Total | $3.68 avg | 55,723 | $205K | 100% |
| Filing → |
| RPTX | BUY | 2023-11-03 | $5.6M | — | Filing → |
| OLMA | BUY | 2023-09-14 | $29.6M | — | Filing → |
| OLMA | BUY | 2022-06-14 | $1.6M | — | Filing → |